Ivana K. Kim

ORCID: 0000-0003-0310-6129
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Diseases and Treatments
  • Retinal Imaging and Analysis
  • Ocular Oncology and Treatments
  • Glaucoma and retinal disorders
  • Retinal and Optic Conditions
  • Retinal Development and Disorders
  • Ocular Diseases and Behçet’s Syndrome
  • Retinal and Macular Surgery
  • Cutaneous Melanoma Detection and Management
  • Single-cell and spatial transcriptomics
  • Corneal Surgery and Treatments
  • Intraocular Surgery and Lenses
  • Ocular Infections and Treatments
  • Metabolomics and Mass Spectrometry Studies
  • Nonmelanoma Skin Cancer Studies
  • Cancer Genomics and Diagnostics
  • Retinoids in leukemia and cellular processes
  • Neurological Disease Mechanisms and Treatments
  • melanin and skin pigmentation
  • Immunotherapy and Immune Responses
  • Lipid metabolism and disorders
  • Angiogenesis and VEGF in Cancer
  • Genetic Associations and Epidemiology
  • Antioxidant Activity and Oxidative Stress
  • Cell Image Analysis Techniques

Harvard University
2016-2025

Massachusetts Eye and Ear Infirmary
2016-2025

University at Buffalo, State University of New York
2018-2022

New York University
2022

University of Wisconsin–Madison
2021

Augusta University Health
2021

Jacobs (United States)
2021

Mansoura University
2021

Augustana University
2021

University of Utah
2018-2020

Lars G. Fritsche Wilmar Igl Jessica N. Cooke Bailey Felix Graßmann Sebanti Sengupta and 95 more Jennifer L. Bragg‐Gresham Kathryn P. Burdon Scott J. Hebbring Cindy Wen Mathias Gorski Ivana K. Kim David Cho Donald J. Zack Eric H. Souied Hendrik P. N. Scholl Elisa Bala Kristine E Lee David J. Hunter Rebecca J. Sardell Paul Mitchell Joanna E. Merriam Valentina Cipriani Joshua Hoffman Tina Schick Yara T. E. Lechanteur Robyn H. Guymer Matthew P. Johnson Yingda Jiang Chloë M. Stanton Gabriëlle H.S. Buitendijk Xiaowei Zhan Alan Kwong Alexis Boleda Matthew Brooks Linn Gieser Rinki Ratnapriya Kari Branham Johanna R. Foerster John R. Heckenlively Mohammad Othman Brendan J. Vote Helena Liang Emmanuelle Souzeau Ian L. McAllister Timothy Isaacs Janette M. Hall Stewart Lake David A. Mackey Ian J. Constable Jamie E. Craig Terrie Kitchner Zhenglin Yang Zhiguang Su Hongrong Luo Daniel Chen Hong Ouyang Ken Flagg Danni Lin Guanping Mao Henry Ferreyra Klaus Stark Claudia N. von Strachwitz Armin Wolf Caroline Brandl Guenther Rudolph Matthias Olden Margaux A. Morrison Denise J. Morgan Matthew Schu Jeeyun Ahn Giuliana Silvestri Evangelia E. Tsironi Kyu Hyung Park Lindsay A. Farrer Anton Orlin Alexander J. Brucker Mingyao Li Christine A. Curcio Saddek Mohand‐Saïd José‐Alain Sahel Isabelle Audo Mustapha Benchaboune Angela J. Cree Christina Rennie Srinivas Goverdhan Michelle Grunin Shira Hagbi-Levi Peter A. Campochiaro Nicholas Katsanis Frank G. Holz Frédéric Blond Hélène Blanché Jean‐François Deleuze Robert P. Igo Barbara Truitt Neal S. Peachey Stacy M. Meuer Chelsea E. Myers Emily Moore Ronald Klein

10.1038/ng.3448 article EN Nature Genetics 2015-12-21
Lars G. Fritsche Wei Chen Matthew Schu Brian L. Yaspan Yi Yu and 95 more Guðmar Þorleifsson Donald J. Zack Satoshi Arakawa Valentina Cipriani Stephan Ripke Robert P. Igo Gabriëlle H.S. Buitendijk Xueling Sim Daniel E. Weeks Robyn H. Guymer Joanna E. Merriam Peter J. Francis Gregory Hannum Anita Agarwal Ana Maria Armbrecht Isabelle Audo Tin Aung Gaetano R. Barile Mustapha Benchaboune Alan C. Bird Paul N. Bishop Kari Branham Matthew Brooks Alexander J. Brucker William H. Cade Melinda Cain Peter A. Campochiaro Chi Chao Chan Ching‐Yu Cheng Emily Y. Chew Kimberly Chin Itay Chowers David Clayton Radu Cojocaru Yvette P. Conley Belinda K. Cornes Mark J. Daly Baljean Dhillon Albert O. Edwards Εvangelos Εvangelou Jesen Fagerness Henry Ferreyra James S. Friedman Ásbjörg Geirsdóttir Ronnie George Christian Gieger Neel Gupta Stephanie A. Hagstrom Simon Harding Christos Haritoglou John R. Heckenlively Frank G. Holz Guy Hughes John P. A. Ioannidis Tatsuro Ishibashi Peronne Joseph Gyungah Jun Yoichiro Kamatani Nicholas Katsanis Claudia N. Keilhauer Jane C. Khan Ivana K. Kim Yutaka Kiyohara Barbara E.K. Klein Ronald Klein Jaclyn L. Kovach Igor Kozak Clara J. Lee Kristine E. Lee Peter Lichtner Andrew Lotery Thomas Meitinger Paul Mitchell Saddek Mohand‐Saïd Anthony T. Moore Denise J. Morgan Margaux A. Morrison Chelsea E. Myers Adam C. Naj Yusuke Nakamura Yukinori Okada Anton Orlin Maria Carolina Ortube Mohammad Othman Chris Pappas Kyu Hyung Park Gayle J. Pauer Neal S. Peachey Olivier Poch Rinki Ratna Priya Robyn Reynolds Andrea J. Richardson Raymond Ripp Guenther Rudolph Euijung Ryu

10.1038/ng.2578 article EN Nature Genetics 2013-03-03
Wei Chen Dwight Stambolian Albert O. Edwards Kari Branham Mohammad Othman and 95 more Jóhanna Jakobsdóttir Nirubol Tosakulwong Margaret A. Pericak‐Vance Peter A. Campochiaro Michael L. Klein Perciliz L. Tan Yvette P. Conley Atsuhiro Kanda Laura J. Kopplin Yanming Li Katherine J. Augustaitis Athanasios J. Karoukis William K. Scott Anita Agarwal Jaclyn L. Kovach Stephen G. Schwartz Eric A. Postel Matthew Brooks Keith H. Baratz William L. Brown Alexander J. Brucker Anton Orlin Gary C. Brown Allen C. Ho Carl D. Regillo Larry A. Donoso Lifeng Tian Brian Kaderli Dexter Hadley Stephanie A. Hagstrom Neal S. Peachey Ronald Klein Barbara E.K. Klein Norimoto Gotoh Kenji Yamashiro Frederick L. Ferris Jesen Fagerness Robyn Reynolds Lindsay A. Farrer Ivana K. Kim Joan W. Miller Marta Cortón Ángel Carracedo Manuel Sánchez‐Salorio Elizabeth Pugh Kimberly F. Doheny Marı́a Brión Margaret M. DeAngelis Daniel E. Weeks Donald J. Zack Emily Y. Chew John R. Heckenlively Nagahisa Yoshimura Sudha K. Iyengar Peter J. Francis Nicholas Katsanis Johanna M. Seddon Jonathan L. Haines Michael B. Gorin Gonçalo R. Abecasis Anand Swaroop Robert N. Johnson Everett Ai H. Richard McDonald Margaret Stolarczuk Peter R. Pavan Karina K. Billiris Mohan Iyer Matthew M. Menosky Scott E. Pautler Sharon M. Millard G. Baker Hubbard Thomas Aaberg Lindy DuBois Alice T. Lyon Susan Anderson-Nelson Lee M. Jampol David V. Weinberg Annie Muñana Zuzanna Rozenbajgier David H. Orth Jack Cohen Matthew MacCumber Matthew MacCumber Celeste Figliulo Liz Porcz James C. Folk H. Culver Boldt Stephen R. Russell Rachel Ivins Connie J. Hinz Charles C. Barr Steve Bloom Ken Jaegers Brian Kritchman

We executed a genome-wide association scan for age-related macular degeneration (AMD) in 2,157 cases and 1,150 controls. Our results validate AMD susceptibility loci near CFH ( P < 10 −75 ), ARMS2 −59 C2/CFB −20 C3 −9 CFI −6 ). compared our top findings with the Tufts/Massachusetts General Hospital study of advanced (821 cases, 1,709 controls) genotyped 30 promising markers additional individuals (up to 7,749 4,625 controls). With these data, we identified locus TIMP3 (overall = 1.1 × −11...

10.1073/pnas.0912702107 article EN Proceedings of the National Academy of Sciences 2010-04-12

An independent Safety Review Committee (SRC), supported by Novartis Pharma AG, analyzed investigator-reported cases of intraocular inflammation (IOI), endophthalmitis, and retinal arterial occlusion in the phase 3 HAWK HARRIER trials brolucizumab versus aflibercept neovascular age-related macular degeneration (nAMD).A post hoc analysis a subset data from two 2-year, double-masked, multicenter, active-controlled randomized (NCT02307682, NCT02434328).Patients (N = 1817) with untreated, active...

10.1016/j.ophtha.2020.11.011 article EN cc-by-nc-nd Ophthalmology 2020-11-15

Background BAP1 has been shown to be a target of both somatic alteration in high-risk ocular melanomas (OM) and germline inactivation few individuals from cancer-prone families. These findings suggest that constitutional changes may predispose metastatic OM familial permeation deleterious alleles could delineate new cancer syndrome. Design To characterize BAP1's contribution melanoma risk, we sequenced set 100 patients with OM, including 50 cases matched non-metastatic controls, 200...

10.1371/journal.pone.0035295 article EN cc-by PLoS ONE 2012-04-24
Emily Y. Chew Traci E. Clemons Elvira Agrón Amitha Domalpally Tiarnán D L Keenan and 92 more Susan Vitale Claire Weber Douglas C. Smith William G. Christen John Paul SanGiovanni Federick L Ferris Ronald P. Danis Barbara A. Blodi Alan Ruby Andrew N. Antoszyk Ronald Klein Ivana K. Kim Gary E. Fish Wai T. Wong David H. Orth Kourous A. Rezaei Susan B. Bressler GB Hubbard Michael J. Elman Suresh Chandra Thomas R. Friberg Michael Tolentino Darmakusuma Le Mary B. Lansing Jay B. Stallman Paul Edwards Carl W. Baker Michael Novák Ricky D. Isernhagen Todd E. Schneiderman Lawrence S. Halperin Michael H. Lee David S. Boyer Philip J. Rosenfeld Pamela Rath Marc H. Levy Robert H. Rosa John C. Hoskins Clement K. Chan David M. Brown Craig M. Greven J Michael Jumper Linda J. Margulies William N. Rosenthal Richard B. Rosen Glenn Stoller Fadi El Baba W. Copley McLean Ronald Kingsley Alice T. Lyon Jeffrey S. Heier Anne E. Fung Ingrid U. Scott John A. Wells Michael J. Banach Paul M. Beer James C. Folk Joseph I. Maguire Srinivas R. Sadda Richard A. Garfinkel Judy E. Kim Paul Berstein Michael Rauser Richard A. Lewis Barron C. Fishburne Susan S. Huang Nelson R. Sabates Nicola Kim Robert N. Frank Brian C. Joondeph Odette M. Houghton Dean P. Hainsworth Edward Chaum Robert H. Millay Raymond Iezzi Rajendra S. Apte Ron A. Adelman Anita Agrawal Neelakshi Bhagat Lawrence Ulanski Steven D. Schwartz Cynthia Owsley Alan Letson Yu-Guang He Cynthia A. Toth Lawrence S. Morse Michael J. Cooney Sandeep Grover Henry Ferreyra Alexander J. Brucker David DiLoreto Aaron Weinberg

After the Age-Related Eye Disease Study 2 (AREDS2) study, beta carotene component was replaced by lutein/zeaxanthin for development of revised AREDS supplement. However, it is unknown if increased risk lung cancer observed in those assigned persists beyond conclusion AREDS2 trial and there a benefit adding to original supplement that can be with long-term follow-up.To assess 10-year developing late age-related macular degeneration (AMD).This multicenter epidemiologic follow-up study clinical...

10.1001/jamaophthalmol.2022.1640 article EN JAMA Ophthalmology 2022-06-02
Tiarnán D L Keenan Elvira Agrón Amitha Domalpally Traci E. Clemons Freekje van Asten and 95 more Wai T. Wong Ronald Danis Srinivas R. Sadda Philip J. Rosenfeld Michael L. Klein Rinki Ratnapriya Anand Swaroop Frederick L. Ferris Emily Y. Chew Emily Y. Chew Frederick L. Ferris John Paul SanGiovanni Elvira Agrón Traci E. Clemons Anne S. Lindblad Robert Lindblad Nilay S. Shah Robert D. Sperduto Wendy L. McBee Gary Gensler Molly Harrington Alice Henning Katrina Jones Kumar Thotapally Diana Tull Valerie Watson Kayla Williams Christina Gentry Francine Kaufman Christopher N. Morrison Elizabeth Saverino Sherrie Schenning Barbara Blodi Ronald P. Danis Matthew Davis Amitha Domalpally Kathy Glander Gregory Guilfoil Larry D. Hubbard Kristine A. Johnson Ronald Klein Barbara Nardi Michael W. Neider N. Edward Robinson Eileen Rosensteel Hugh Wabers Grace Zhang Alan Ruby Antonio Capone Bawa Dass Kimberly A. Drenser Bruce R. Garretson T. Hassan Michael T. Trese George A. Williams Jeremy D. Wolfe Tina Bell Mary Zajechowski Dennis Bezaire Fran McIver Anthony Medina Jackie Pagett Stephanie Hatch Smith Lynn Swartz Tom Treuter Andrew N. Antoszyk Justin C. Brown David J. Browning Walter Holland Angella S. Karow Kelly Stalford Angela Price Sarah Ennis Sherry L. Fredenberg Jenna Herby Uma Balasubramaniam Loraine Clark Donna McClain Michael McOwen Lynn Watson Michael L. Klein Steven T. Bailey Thomas J. Hwang Andreas Lauer J. Timothy Stout Patty McCollum Milt Johnson Patrick B. Rice Ivana K. Kim John I. Loewenstein Joan W. Miller Lucia Sobrin Lucy H. Young Jacqueline Sullivan Patricia Houlihan

10.1016/j.ophtha.2018.05.028 article EN publisher-specific-oa Ophthalmology 2018-07-27

Age-related macular degeneration (AMD) remains the leading cause of blindness in developed countries, and affects more than 150 million worldwide. Despite effective anti-angiogenic therapies for less prevalent neovascular form AMD, treatments are lacking dry form. Similarities risk factors pathogenesis between AMD atherosclerosis have led investigators to study effects statins on incidence progression with mixed results. A limitation these studies has been heterogeneity disease lack...

10.1016/j.ebiom.2016.01.033 article EN cc-by-nc-nd EBioMedicine 2016-02-04

Abstract Single-cell RNA-seq is a powerful tool in decoding the heterogeneity complex tissues by generating transcriptomic profiles of individual cell. Here, we report single-nuclei (snRNA-seq) study on human retinal tissue, which composed multiple cell types with distinct functions. Six samples from three healthy donors are profiled and high-quality data obtained for 5873 single nuclei. All major observed marker genes each type identified. The gene expression macular peripheral retina...

10.1038/s41467-019-12917-9 article EN cc-by Nature Communications 2019-12-17

<h3>Importance</h3> Despite high rates of local tumor control in patients who are treated for uveal melanoma, most will eventually die metastasis. When metastasis develops, the liver is involved cases, and hepatic metastases particularly refractory to treatment. Finding effective treatments has been challenging. A comparison survival were over approximately 30 years may offer insights into progress that made prolonging survival. <h3>Objective</h3> To compare after treatment a cohort melanoma...

10.1001/jamaophthalmol.2018.2466 article EN JAMA Ophthalmology 2018-06-28

<h3>Importance</h3> Somatic mutations in<i>BAP1</i>(BRCA1-associated protein 1 gene) are frequently identified in uveal melanoma. To date, the role of germline<i> BAP1</i>mutations melanoma has not been characterized. <h3>Objective</h3> characterize clinical phenotype patients with germline<i>BAP1</i>mutations. <h3>Design, Setting, and Participants</h3> Retrospective cohort study at an academic ophthalmology referral center among 507 who consented for collection blood samples. The dates were...

10.1001/jamaophthalmol.2015.1119 article EN JAMA Ophthalmology 2015-05-14

Purpose.: Difficulty with night vision is a common complaint of patients age-related macular degeneration (AMD). Consistent this complaint, dark adaptation (DA) substantially impaired in these patients. Because the severity deficit, measurement DA has been suggested as means for diagnosis AMD. Previous methods were time intensive (>30 minutes), which made them unsuitable clinical use. This study evaluated rapid test (≤6.5 minutes) detection Methods.: Dark was measured by using AdaptDx...

10.1167/iovs.13-13745 article EN Investigative Ophthalmology & Visual Science 2014-02-18

Cell classes in the human retina are highly heterogeneous with their abundance varying by several orders of magnitude. Here, we generated and integrated a multi-omics single-cell atlas adult retina, including more than 250,000 nuclei for single-nuclei RNA-seq 137,000 ATAC-seq. Cross-species comparison among human, monkey, mice, chicken revealed relatively conserved non-conserved types. Interestingly, overall cell heterogeneity primate decreases compared that rodent retina. Through...

10.1016/j.xgen.2023.100298 article EN cc-by-nc-nd Cell Genomics 2023-04-11
Coming Soon ...